Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot comparison of intravenous methylprednisolone versus plasma exchange for acute neuromyelitis optica attacks
TCTR20160314002Phase 2Recruiting
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in Neuromyelitis Optica Spectrum Disorder (NMOSD), sponsored by none. Started Mar 2016; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Beyond the preview
Go deeper on TCTR20160314002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160314002.